‘Close to the Line’: Why More Seniors Are Living in Poverty
Benefits extended earlier in the coronavirus pandemic have been rolled back. But many older Americans are not taking advantage of the aid still available.
We do not offer every plan available in your area. Currently we represent eight carriers which offers forty-five products in your area. Please contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Program (SHIP) to get information on all of your options. Licensed health insurance agent – not affiliated with the Government.
Call To Schedule Your Consultation
425-818-9915
By calling this number, I understand I will be directed
to a licensed insurance sales agent or broker.
Please complete the form below and we will contact you shortly.
This is a solicitation of insurance. By providing this information, you agree that an authorized representative or licensed insurance agent/producer may contact you by phone, email, or mail to answer your questions or provide additional information about Medicare Advantage, Part D or Medicare Supplement Insurance policies.
Benefits extended earlier in the coronavirus pandemic have been rolled back. But many older Americans are not taking advantage of the aid still available.
Now that the U.S. government has stepped back from issuing vaccines, long-term care operators have yet to start administering shots to protect one of the most vulnerable populations.
Readers offered theories of their own on a big budget mystery.
Instead of growing and growing, as it always had, spending per Medicare beneficiary has nearly leveled off over more than a decade.
Most Americans support lowering drug prices.
Readers assess Joe Biden’s accomplishments and shortcomings. Also: Drug price negotiations; a groundwater crisis; cancer, or not; training horses.
Lowering the prices of vital drugs is worthwhile, but innovation could suffer if the government isn’t careful.
A negotiation program is projected to save the government tens of billions of dollars in the coming years.
President Biden’s Inflation Reduction Act allows Medicare to negotiate some drug prices, a change that the pharmaceutical industry and Republicans have opposed for decades.
After his administration announced the first set of medications selected for Medicare price negotiations, President Biden vowed to continue standing up to the pharmaceutical industry over the cost of drugs.